Testosterone induces cytoprotection by activating ATP-sensitive K + channels in the cardiac mitochondrial inner membrane

Circulation

Volumn 110, Issue 19, 2004, Pages 3100-3107

  Er, Fikret ^a   Michels, Guido ^a   Gassanov, Natig ^a   Rivero, Francisco ^a   Hoppe, Uta C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Electrophysiology; Hormones; Ion channels; Myocytes; Preconditioning

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; CLAMIKALANT; DIAZOXIDE; FLAVOPROTEIN; FLUTAMIDE; GLIBENCLAMIDE; HORMONE RECEPTOR; PINACIDIL; POTASSIUM CHANNEL; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; ISCHEMIA; MITOCHONDRIAL MEMBRANE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SARCOPLASM;

ADENOSINE TRIPHOSPHATE; ANDROSTENEDIONE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELLS, CULTURED; DIAZOXIDE; FLUTAMIDE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; ION TRANSPORT; MALE; MEMBRANE PROTEINS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PINACIDIL; POTASSIUM; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; SARCOPLASMIC RETICULUM; TESTOSTERONE;

EID: 8544264595     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000146900.84943.E0     Document Type: Article

References (29)

1. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183-217.
2. Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med. 2004;350:482-492.
3. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 1995;15:562-570.
4. Melchert RB, Welder AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc. 1995;27:1252-1262.
5. English KM, Jones RD, Jones TH, Morice AH, Channer KS. Testosterone acts as a coronary vasodilator by a calcium antagonistic action. J Endocrinol Invest. 2002;25:455-458.
6. Callies F, Stromer H, Schwinger RH, Bolck B, Hu K, Frantz S, Leupold A, Beer S, Allolio B, Bonz AW. Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology. 2003;144:4478-4483.
7. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281: 1309-1312.
8. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2469.
9. Shake JG, Peck EA, Marban E, Gott VL, Johnston MV, Troncoso JC, Redmond JM, Baumgartner WA. Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann Thorac Surg. 2001;72:1849-1854.
10. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81: 1072-1082.
11. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res. 2004;94:7-16.
12. + channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
13. + uniport in intact mitochondria by adenine nucleotides and nucleotide analogs. J Biol Chem. 1993;268:997-1004.
14. Garlid KD. Cation transport in mitochondria: the potassium cycle. Biochim Biophys Acta. 1996;1275:123-126.
15. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res. 2001;89: 1177-1183.
16. Das M, Parker JE, Halestrap AP. Matrix volume measurements challenge the existence of diazoxide/glibenclamide-sensitive KATP channels in rat mitochondria. J Physiol. 2003;547:893-902.
17. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol. 2002;542:735-741.
18. Schafer G, Portenhauser R, Trolp R. Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide, I: action on succinate dehydrogenase and TCA-cycle oxidations. Biochem Pharmacol. 1971;20: 1271-1280.
19. Lawrence CL, Billups B, Rodrigo GC, Standen NB. The KATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br J Pharmacol. 2001;134:535-542.
20. Hoppe UC, Marbán E, Johns DC. Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1. Proc Natl Acad Sci U S A. 2001;98: 5335-5340.
21. + channels in the cardiac inner mitochondrial membrane. Science. 2002;298:1029-1033.
22. Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature. 2004;427:360-364.
23. Vander Heide RS, Rim D, Hohl CM, Ganote CE. An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes. J Mol Cell Cardiol. 1990;22:165-181.
24. Klingenberg M. The ADP-ATP translocation in mitochondria, a membrane potential controlled transport. J Membr Biol. 1980;56:97-105.
25. Heald AH, Ivison F, Anderson SG, Cruickshank K, Laing I, Gibson JM. Significant ethnic variation in total and free testosterone concentration. Clin Endocrinol (Oxf). 2003;58:262-266.
26. Gross GJ, Peart JN. KATP channels and myocardial preconditioning: an update. Am J Physiol. 2003;285:H921-H930.
27. + channel from rat liver and beef heart mitochondria. J Biol Chem. 1992;267:26062-26069.
28. Reid J, Betney R, Watt K, McEwan IJ. The androgen receptor transactivation domain: the interplay between protein conformation and protein-protein interactions. Biochem Soc Trans. 2003;31:1042-1046.
29. Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis. 1996;125:1-13.